SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193805-24-000203
Filing Date
2024-02-13
Accepted
2024-02-13 16:36:14
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 e619263_s3-immunic.htm S-3 229852
2 OPINION OF DENTONS US LLP e619263_ex5-1.htm EX-5.1 10006
3 CONSENT OF BAKER TILLY US, LLP e619263_ex23-1.htm EX-23.1 2021
4 e619263_ex107.htm EX-FILING FEES 18170
5 GRAPHIC image_001.jpg GRAPHIC 5865
6 GRAPHIC image_002.jpg GRAPHIC 38201
7 GRAPHIC image_003.jpg GRAPHIC 2322
8 GRAPHIC image_004.jpg GRAPHIC 3324
9 GRAPHIC image_005.jpg GRAPHIC 3394
  Complete submission text file 0001193805-24-000203.txt   334988
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277040 | Film No.: 24626708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)